Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Barinthus Biotherapeutics plc - American Depositary Shares (NQ:BRNS)

0.5999 UNCHANGED

Streaming Delayed Price Updated: 3:59 PM EDT, Aug 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	100
Open	0.6000
Bid (Size)	0.5200 (8,000)
Ask (Size)	0.6010 (400)
Prev. Close	0.5999
Today's Range	0.5501 - 0.6004
52wk Range	0.5120 - 1.830
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 20, 2026

Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million. Barinthus Biotherapeutics...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 17, 2026

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market session. The market value of their outstanding shares is at $112.9 million. Barinthus Biotherapeutics...

Via Benzinga

Performance

YTD	-18.4%	-18.4%
1 Month	-4.9%	-4.9%
3 Month	-5.5%	-5.5%
6 Month	-17.3%	-17.3%
1 Year	-53.5%	-53.5%

More News

Barinthus Biotherapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS

May 11, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC is Investigating Whether TBRG, SILA, BRNS are Obtaining Fair Deals for their Shareholders

April 30, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments

April 30, 2026

From Barinthus Biotherapeutics

Via GlobeNewswire

Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments

March 13, 2026

From Barinthus Biotherapeutics

Via GlobeNewswire

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

December 10, 2025

From Barinthus Biotherapeutics

Via GlobeNewswire

Halper Sadeh LLC Encourages HFWA, BRNS, FITB Shareholders to Contact the Firm to Discuss Their Rights

November 20, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages HFWA, FITB, AVDL, BRNS Shareholders to Contact the Firm to Discuss Their Rights

November 18, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Top movers in Monday's session ↗

November 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

November 07, 2025

From Barinthus Biotherapeutics

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)

October 16, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates DAY, BRNS, ETNB, VRNT on Behalf of Shareholders

October 08, 2025

From Halper Sadeh LLC

Via GlobeNewswire

October 08, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 07, 2025

Via Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECO, BRNS, VRNT on Behalf of Shareholders

October 04, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS

October 03, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 01, 2025

Via Benzinga

BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics plc Is Fair to Shareholders

September 30, 2025

From Halper Sadeh LLC

Via Business Wire

Barinthus Biotherapeutics To Merge With Privately-Held Clywedog Therapeutics ↗

September 30, 2025

Via Stocktwits

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

September 30, 2025

From Barinthus Biotherapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 11, 2025

Via Benzinga

Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments

August 07, 2025

From Barinthus Biotherapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 21, 2025

Via Benzinga

Frequently Asked Questions

Is Barinthus Biotherapeutics plc - American Depositary Shares publicly traded?

Yes, Barinthus Biotherapeutics plc - American Depositary Shares is publicly traded.

What exchange does Barinthus Biotherapeutics plc - American Depositary Shares trade on?

Barinthus Biotherapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Barinthus Biotherapeutics plc - American Depositary Shares?

The ticker symbol for Barinthus Biotherapeutics plc - American Depositary Shares is BRNS on the Nasdaq Stock Market

What is the current price of Barinthus Biotherapeutics plc - American Depositary Shares?

The current price of Barinthus Biotherapeutics plc - American Depositary Shares is 0.5999

When was Barinthus Biotherapeutics plc - American Depositary Shares last traded?

The last trade of Barinthus Biotherapeutics plc - American Depositary Shares was at 08/03/26 03:59 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.